Nature Communications

Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial

2026-01-05

Full text

DOI https://doi.org/10.1038/s41467-025-67646-z